Get startedLog in
    Picture of Calliditas Therapeutics AB logo

    CALT — Calliditas Therapeutics AB News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    All News

    Brief: Calliditas Therapeutics: Updated Regulatory Plans For NEFECON In China

    Picture of Calliditas Therapeutics AB logoCalliditas Therapeutics AB
    18/03/2022 10:50
    March 18 (Reuters) - 
    * UPDATED REGULATORY PLANS FOR NEFECON IN CHINA
    * PARTNER EVEREST MEDICINES (HKEX 1952.HK) PLANS TO SUBMIT
AN NDA
FOR NEFECON IN CHINA IN SECOND HALF OF 2022.
    * EVEREST PLANS TO CONDUCT AN INTERIM ANALYSIS OF CHINESE
PATIENTS
EXPECTS  REGULATORY SUBMISSION IN CHINA IN 2H OF 2022.

Source text for Eikon:  ID:nWkr8ZrtlC 
Further company coverage: [ CALTX.ST ]

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Calliditas Therapeutics AB

    See all news